Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping

Abstract

UNLABELLED Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of genetically heterologous or homologous P. vivax infection recurrence following receipt of… (More)
DOI: 10.1093/infdis/jiv508

Topics

2 Figures and Tables

Slides referencing similar topics